A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and ...
Amprius Technologies reports 173% growth and 15% margins; UAV scaling, manufacturing, and valuation risks define the outlook.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results